Researcher.Life Logo

Harvard Business Review : Impact Factor & More

eISSN: 0017-8012pISSN: 0017-8012

Key Metrics

CiteScore
3.9
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
SJR
Q2Strategy and Management
SNIP
3.1
Recommended pre-submission checks
Powered by Paperpal by Editage

Harvard Business Review Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher HARVARD BUSINESS SCHOOL PUBLISHING CORPORATION
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1922
Publisher URLVisit website
View less

Planning to publish in Harvard Business Review ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Harvard Business Review

WISP-3 enhances proinflammatory cytokine IL-1β production in rheumatoid arthritis through the FAK, JNK and AP-1 pathways.
  • 1 Jul 2026
  • Cellular immunology
UVB induces DNA hypomethylation and cell activation in CD4+ T cells of systemic lupus erythematosus via miR-410 regulating GADD45A.
  • 1 Jul 2026
  • Cellular immunology
Armed oncolytic adenovirus elicits a "self-feeder" effect to supercharge NK cells for solid tumor control.
  • 1 May 2026
  • Cellular immunology
FGF20 alleviates neuroinflammation in ischemic stroke by modulating microglial polarization via TREM2-TLR4/NF-κB pathway.
  • 1 May 2026
  • Cellular immunology
Tumor resection may abort the antitumor immune response produced from primary foci.
  • 1 May 2026
  • Cellular immunology
MFG-E8 inhibits AT1-AA production to alleviate preeclampsia.
  • 1 Apr 2026
  • Cellular immunology
WISP-3 enhances proinflammatory cytokine IL-1β production in rheumatoid arthritis through the FAK, JNK and AP-1 pathways.
  • 1 Jul 2026
  • Cellular immunology
UVB induces DNA hypomethylation and cell activation in CD4+ T cells of systemic lupus erythematosus via miR-410 regulating GADD45A.
  • 1 Jul 2026
  • Cellular immunology
Armed oncolytic adenovirus elicits a "self-feeder" effect to supercharge NK cells for solid tumor control.
  • 1 May 2026
  • Cellular immunology
FGF20 alleviates neuroinflammation in ischemic stroke by modulating microglial polarization via TREM2-TLR4/NF-κB pathway.
  • 1 May 2026
  • Cellular immunology
Tumor resection may abort the antitumor immune response produced from primary foci.
  • 1 May 2026
  • Cellular immunology
MFG-E8 inhibits AT1-AA production to alleviate preeclampsia.
  • 1 Apr 2026
  • Cellular immunology

FAQs on Harvard Business Review